FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Home Diagnostics, Inc. (Nasdaq:HDIX), a leading manufacturer and marketer of diabetes testing supplies, announced today that on March 2, 2007, the United States District Court, Southern District of Indiana, Indianapolis Division granted a Summary Judgment ruling in favor of Home Diagnostics for non-infringement and denied the Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc. and Corange International Ltd. (collectively, “Roche”) motion for a Summary Judgment of patent infringement in the patent infringement lawsuit over the TrueTrack Smart System® and TrackEASE Smart System®. In their complaint, Roche alleges that the TrueTrack and TrackEASE blood glucose monitors infringe on U.S. Patent No. 5,366,609, relating to a biosensing blood glucose monitor with a pluggable memory module.
